ANTX Financial Statements

Balance sheet, income statement, cash flow, and dividends for An2 Therapeutics Inc (ANTX).


$41.23M Market Cap.

As of 03/25/2025 5:00 PM ET (MRY) • Disclaimer

ANTX Market Cap. (MRY)


ANTX Shares Outstanding (MRY)


ANTX Assets (MRY)


Total Assets

$92.09M

Total Liabilities

$10.24M

Total Investments

$67.29M

ANTX Income (MRY)


Revenue

$0

Net Income

-$51.32M

Operating Expense

$56.79M

ANTX Cash Flow (MRY)


CF Operations

-$49.26M

CF Investing

$54.59M

CF Financing

$372.00K

ANTX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

-

0%

0%

-

2020

$0

-

-

0%

-

ANTX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$92,087,000 (-33.63%)

$138,744,000 (35.28%)

$102,560,000 (57.02%)

$65,316,000 (1442.65%)

Assets Current

$86,262,000 (-21.94%)

$110,507,000 (12.05%)

$98,621,000 (64.08%)

$60,106,000 (1319.60%)

Assets Non-Current

$5,825,000 (-79.37%)

$28,237,000 (616.86%)

$3,939,000 (-24.40%)

$5,210,000 (0%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$81,849,000 (-34.36%)

$124,701,000 (30.75%)

$95,372,000 (301.16%)

-$47,411,000 (-133.33%)

Property Plant & Equipment Net

$0 (0%)

$0 (0%)

$53,000 (0%)

$0 (0%)

Cash & Equivalents

$21,351,000 (36.45%)

$15,647,000 (-42.51%)

$27,219,000 (125.01%)

$12,097,000 (197.22%)

Accumulated Other Comprehensive Income

$31,000 (-88.73%)

$275,000 (173.53%)

-$374,000 (-1285.19%)

-$27,000 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$67,288,000 (-43.38%)

$118,842,000 (64.92%)

$72,059,000 (44.28%)

$49,944,000 (0%)

Investments Current

$62,267,000 (-32.06%)

$91,648,000 (33.13%)

$68,840,000 (48.18%)

$46,458,000 (0%)

Investments Non-Current

$5,021,000 (-81.54%)

$27,194,000 (744.80%)

$3,219,000 (-7.66%)

$3,486,000 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$3,317,000 (23.95%)

$2,676,000 (26.11%)

$2,122,000 (99.62%)

$1,063,000 (705.30%)

Accumulated Retained Earnings (Deficit)

-$205,776,000 (-33.23%)

-$154,455,000 (-72.15%)

-$89,723,000 (-89.35%)

-$47,384,000 (-133.20%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$0 (0%)

$0 (0%)

$53,000 (0%)

$0 (0%)

Debt Current

$0 (0%)

$0 (0%)

$53,000 (0%)

$0 (0%)

Debt Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Liabilities

$10,238,000 (-27.10%)

$14,043,000 (95.37%)

$7,188,000 (110.92%)

$3,408,000 (129.80%)

Liabilities Current

$10,238,000 (-27.10%)

$14,043,000 (95.42%)

$7,186,000 (111.66%)

$3,395,000 (132.69%)

Liabilities Non-Current

$0 (0%)

$0 (0%)

$2,000 (-84.62%)

$13,000 (-45.83%)

ANTX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$14,066,000 (-4.73%)

$14,764,000 (15.79%)

$12,751,000 (173.16%)

$4,668,000 (269.01%)

Research & Development Expense

$40,488,000 (-26.21%)

$54,871,000 (85.93%)

$29,511,000 (74.56%)

$16,906,000 (180.88%)

Operating Expenses

$56,788,000 (-18.45%)

$69,635,000 (64.59%)

$42,307,000 (95.76%)

$21,612,000 (58.84%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$51,321,000 (20.72%)

-$64,732,000 (-58.05%)

-$40,956,000 (-90.11%)

-$21,543,000 (-58.37%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$51,321,000 (20.72%)

-$64,732,000 (-58.05%)

-$40,956,000 (-90.11%)

-$21,543,000 (-58.37%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$1,820,000 (-72.06%)

$6,515,000 (564.12%)

Net Income Common Stock

-$51,321,000 (20.72%)

-$64,732,000 (-51.33%)

-$42,776,000 (-52.46%)

-$28,058,000 (-92.39%)

Weighted Average Shares

$29,828,227 (26.39%)

$23,600,107 (53.85%)

$15,340,134 (481.46%)

$2,638,197 (2.71%)

Weighted Average Shares Diluted

$29,828,227 (26.39%)

$23,600,107 (53.85%)

$15,340,134 (481.46%)

$2,638,197 (2.71%)

Earning Before Interest & Taxes (EBIT)

-$51,321,000 (20.72%)

-$64,732,000 (-58.05%)

-$40,956,000 (-90.11%)

-$21,543,000 (-58.37%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$56,788,000 (18.45%)

-$69,635,000 (-64.59%)

-$42,307,000 (-95.76%)

-$21,612,000 (-58.84%)

ANTX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$54,589,000 (226.14%)

-$43,278,000 (-98.79%)

-$21,771,000 (56.48%)

-$50,024,000 (0%)

Net Cash Flow from Financing

$372,000 (-99.56%)

$84,994,000 (20.81%)

$70,355,000 (-10.42%)

$78,535,000 (1947.31%)

Net Cash Flow from Operations

-$49,257,000 (7.56%)

-$53,288,000 (-59.25%)

-$33,462,000 (-63.36%)

-$20,484,000 (-281.88%)

Net Cash Flow / Change in Cash & Cash Equivalents

$5,704,000 (149.29%)

-$11,572,000 (-176.52%)

$15,122,000 (88.39%)

$8,027,000 (625.33%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$54,589,000 (226.14%)

-$43,278,000 (-98.79%)

-$21,771,000 (56.48%)

-$50,024,000 (0%)

Capital Expenditure

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$372,000 (-99.56%)

$84,994,000 (20.81%)

$70,355,000 (639490.91%)

$11,000 (-82.81%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$8,338,000 (-0.88%)

$8,412,000 (91.57%)

$4,391,000 (350.82%)

$974,000 (2335.00%)

Depreciation Amortization & Accretion

$0 (0%)

$53,000 (-31.17%)

$77,000 (0%)

$0 (0%)

ANTX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-54.20% (9.21%)

-59.70% (-50.76%)

-39.60% (-147.77%)

82.90%

Return on Average Assets (ROAA)

-48.90% (8.94%)

-53.70% (-42.06%)

-37.80% (53.16%)

-80.70%

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-75.40% (7.37%)

-81.40% (-25.81%)

-64.70% (27.14%)

-88.80%

Dividend Yield

0% (0%)

0% (0%)

0%

-

Price to Earnings Ratio (P/E)

-0.8 (89.28%)

-7.48 (-118.91%)

-3.42

-

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

0.5 (-89.69%)

4.89 (152.04%)

1.94

-

Debt to Equity Ratio (D/E)

0.13 (10.62%)

0.11 (50.67%)

0.07 (204.17%)

-0.07 (1.37%)

Earnings Per Share (EPS)

-1.72 (37.23%)

-2.74 (1.79%)

-2.79 (73.78%)

-10.64 (-87.32%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-1.65 (26.88%)

-2.26 (-3.53%)

-2.18 (71.91%)

-7.76 (-271.84%)

Book Value Per Share (BVPS)

2.74 (-48.07%)

5.28 (-15.01%)

6.22 (134.59%)

-17.97 (-127.19%)

Tangible Assets Book Value Per Share (TABVPS)

3.09 (-47.49%)

5.88 (-12.07%)

6.69 (-72.99%)

24.76 (1402.31%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

-9 (-125.00%)

-4

-

Enterprise Value Over EBITDA (EV/EBITDA)

-0.15 (98.31%)

-8.92 (-133.39%)

-3.82

-

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0

Current Ratio

8.43 (7.08%)

7.87 (-42.66%)

13.72 (-22.48%)

17.7 (510.06%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$49,257,000 (7.56%)

-$53,288,000 (-59.25%)

-$33,462,000 (-63.36%)

-$20,484,000 (-281.88%)

Enterprise Value (EV)

$7,728,868 (-98.66%)

$576,786,208 (269.31%)

$156,178,331

-

Earnings Before Tax (EBT)

-$51,321,000 (20.72%)

-$64,732,000 (-58.05%)

-$40,956,000 (-90.11%)

-$21,543,000 (-58.37%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$51,321,000 (20.65%)

-$64,679,000 (-58.22%)

-$40,879,000 (-89.76%)

-$21,543,000 (-58.37%)

Invested Capital

$60,498,000 (-44.52%)

$109,054,000 (59.88%)

$68,208,000 (36.90%)

$49,824,000 (3947.41%)

Working Capital

$76,024,000 (-21.19%)

$96,464,000 (5.50%)

$91,435,000 (61.23%)

$56,711,000 (1943.64%)

Tangible Asset Value

$92,087,000 (-33.63%)

$138,744,000 (35.28%)

$102,560,000 (57.02%)

$65,316,000 (1442.65%)

Market Capitalization

$41,232,868 (-93.23%)

$609,402,208 (229.57%)

$184,907,331

-

Average Equity

$94,618,000 (-12.78%)

$108,487,750 (0.40%)

$108,054,500 (419.07%)

-$33,865,000

Average Assets

$104,879,250 (-13.06%)

$120,640,500 (6.51%)

$113,271,750 (225.73%)

$34,775,000

Invested Capital Average

$68,038,750 (-14.47%)

$79,554,000 (25.65%)

$63,312,000 (160.92%)

$24,264,500

Shares

29,878,890 (0.46%)

29,741,445 (53.29%)

19,402,658 (6.96%)

18,139,786